Follow
Claudio Festuccia
Claudio Festuccia
Verified email at univaq.it - Homepage
Title
Cited by
Cited by
Year
Bombesin stimulates growth of human prostatic cancer cells in vitro
M Bologna, C Festuccia, P Muzi, L Biordi, M Ciomei
Cancer 63, 1714-1720, 1989
2821989
Nucleo-cytoplasmic transport as a therapeutic target of cancer
GL Gravina, W Senapedis, D McCauley, E Baloglu, S Shacham, ...
Journal of hematology & oncology 7, 1-9, 2014
2662014
Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors.
R De Maria, MG Cifone, R Trotta, MR Rippo, A Santoni, T Roberto
Journal of Experimental Medicine 180, 1999-2004, 1994
2291994
Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
V Dolo, S D'Ascenzo, S Violini, L Pompucci, C Festuccia, A Ginestra, ...
Clinical & experimental metastasis 17, 131-140, 1999
2041999
Vitamin D Protects Human Endothelial Cells from H2O2 Oxidant Injury Through the Mek/Erk-Sirt1 Axis Activation
L Polidoro, G Properzi, F Marampon, GL Gravina, C Festuccia, ...
Journal of cardiovascular translational research 6, 221-231, 2013
1642013
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
GL Gravina, C Festuccia, F Marampon, VM Popov, RG Pestell, BM Zani, ...
Molecular cancer 9, 1-16, 2010
1592010
Plasminogen activator system modulates invasivecapacity and proliferation in prostatic tumor cells
C Festuccia, V Dolo, F Guerra, S Violini, P Muzi, A Pavan, M Bologna
Clinical & experimental metastasis 16, 513-528, 1998
1321998
Antitumor effects of saffron-derived carotenoids in prostate cancer cell models
C Festuccia, A Mancini, GL Gravina, L Scarsella, S Llorens, GL Alonso, ...
BioMed research international 2014, 2014
1292014
Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2
F Casilli, A Bianchini, I Gloaguen, L Biordi, E Alesse, C Festuccia, ...
Biochemical pharmacology 69 (3), 385-394, 2005
1292005
Osteoblast conditioned media contain TGF‐β1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components
C Festuccia, M Bologna, GL Gravina, F Guerra, A Angelucci, I Villanova, ...
International journal of cancer 81 (3), 395-403, 1999
1241999
Crocus sativus stigma extract and its major constituent crocin possess significant antiproliferative properties against human prostate cancer
AM D’Alessandro, A Mancini, AR Lizzi, A De Simone, CE Marroccella, ...
Nutrition and cancer 65 (6), 930-942, 2013
1212013
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
A Angelucci, GL Gravina, N Rucci, D Millimaggi, C Festuccia, P Muzi, ...
Endocrine-related cancer 13 (1), 197-210, 2006
1132006
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines
A Angelucci, S D'Ascenzo, C Festuccia, GL Gravina, M Bologna, V Dolo, ...
Clinical & experimental metastasis 18, 163-170, 2000
1092000
From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis
I Giusti, S Delle Monache, M Di Francesco, P Sanità, S D’Ascenzo, ...
Tumor Biology 37, 12743-12753, 2016
1032016
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro
I Recchia, N Rucci, C Festuccia, M Bologna, AR MacKay, S Migliaccio, ...
European Journal of Cancer 39 (13), 1927-1935, 2003
1022003
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures
C Vicentini, C Festuccia, GL Gravina, A Angelucci, A Marronaro, ...
Journal of cancer research and clinical oncology 129, 165-174, 2003
992003
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity
C Festuccia, A Angelucci, GL Gravina, L Biordi, D Millimaggi, P Muzi, ...
Thrombosis and haemostasis 93 (05), 964-975, 2005
962005
MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals
F Marampon, GL Gravina, A Di Rocco, P Bonfili, M Di Staso, C Fardella, ...
Molecular cancer therapeutics 10 (1), 159-168, 2011
942011
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro
C Festuccia, P Muzi, GL Gravina, D Millimaggi, S Speca, V Dolo, ...
International journal of oncology 30 (1), 193-200, 2007
902007
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells
F Marampon, F Megiorni, S Camero, C Crescioli, HP McDowell, R Sferra, ...
Cancer letters 397, 1-11, 2017
892017
The system can't perform the operation now. Try again later.
Articles 1–20